A random clinical trial and test conducted by the medical researchers found that the patients who received a genetic test for the lowering of cholesterol and their side effects in the body did not possess worst outcomes in a year of the trial.
Some laboratories across the world offer the Pharmacogenetic testing – which depicts the patients’ ability to the vulnerable side effects of certain medications, by studying their genetic structure. However, the FDA raised concerns on this issue as the people might self-medicate based on the results of pharmacogenetic testing, which an cause harm sooner or later.
